Biotech Values

[swampboots]

Further reading of that summary suggests that the largest "complex" effort ever put together in cancer science is quietly under way in this neoantigen field,...............because in my humble opinion, the causal sufficiency and end point accuracy of this strategy has for years been sidelined by the necessity of mining an infinity of new data, but the recent organizing of the skillful taskings "frisking" the elite contributions of...."36 top biotechnology, pharmaceutical, university, and non-profit research teams, consisting of the National Cancer Center (NCC), PICI, Memorial Sloan-Kettering Cancer Center (MSKCC), MD Anderson Cancer Center, and more than 30 other top neoantigen research institutions", may save eons of time). " The consortium aims to establish algorithms and standards for global neoantigen testing, make concerted efforts to predict more precise anticancer targets, and advance research and application of personalized tumor vaccines. TESLA scientists discovered algorithmic models and core parameters that can better predict neoantigens and accurately predicted 75% of validated neoantigen targets and filtered to exclude 98% of invalid neoantigen targets, whose findings were published in cell journals (81)."